I On May 30, 2025, Conjustar Biologics announced that it's EphA2 targeting PDC drug SC-102 has received Investigational New Drug (IND) approval ...

BEIJING, China & NANJING, China, China I June 04, 2025 I Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai ...

SHANGHAI, China & INDIANAPOLIS, IN, USA I June 04, 2025 I Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development ...

The PLATFORM-CM trial is evaluating oteseconazole and other investigational products against the standard of care for treating cryptococcal meningitis DURHAM, NC, USA I June 4, 2025 I Mycovia ...

SHANGHAI, China and CHICAGO, IL, USA I June 5, 2025 I The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio ...

I Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of ...

LEUVEN, Belgium I June 5, 2025 I AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on ...

HONG KONG, China I June 3, 2025 I Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that denifanstat (ASC40), a first-in-class, once-daily oral ...

BASEL, Switzerland I June 04, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved a label extension for ...

Phase 1 trial demonstrates encouraging clinical activity of investigational immunotherapy for relapsed or refractory multiple myeloma ...

LUND, Sweden and INDIANAPOLIS, IN, USA I June 3, 2025 I Camurus (NASDAQ STO: CAMX) and Eli Lilly and Company ("Lilly") have entered a collaboration and ...

WHIPPANY, NJ, USA I June 03, 2025 I Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved its oral androgen receptor inhibitor ...